Search results
Orchard (ORTX) Up 97% on $478M Acquisition Deal With Kyowa Kirin
Zacks via Yahoo News· 9 months agoOrchard (ORTX) is set to be acquired by Kyowa Kirin for a consideration of $17 per American...
Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks via Yahoo News· 2 months agoUltragenyx (RARE) reports dismal first-quarter 2024 results, missing both earnings and revenue...
Ultragenyx (RARE) Q3 Earnings and Revenues Miss Estimates
Zacks via Yahoo News· 8 months agoUltragenyx (RARE) reports weaker-than-expected third-quarter 2023 results, missing earnings and...
Reata (RETA) Q3 Earnings Beat, Stock Up on Pipeline Updates
Zacks via Yahoo News· 2 years agoReata (RETA) reports a narrower-than-expected loss in the third quarter. Stock rises after RETA...
Amgen (AMGN) Beats on Q3 Earnings & Sales, Tweaks 2022 View
Zacks via Yahoo News· 2 years agoAmgen AMGN reported third-quarter 2022 earnings of $4.70 per share, which beat the Zacks Consensus...
Ultragenyx's (RARE) Q3 Earnings Miss Estimates, Revenues Up Y/Y
Zacks via Yahoo News· 2 years agoUltragenyx Pharmaceutical Inc. RARE incurred a loss of $3.50 per share in third-quarter 2022, which...
Why Is Reata Pharmaceuticals, Inc. (RETA) Up 6.9% Since Last Earnings Report?
Zacks via Yahoo News· 1 year agoA month has gone by since the last earnings report for Reata Pharmaceuticals, Inc. (RETA). Shares...
Ultragenyx (RARE) Sells Portion of Royalty Interest for $500M
Zacks via Yahoo News· 2 years agoUltragenyx (RARE) sells 30% of the royalty interest receivable on future North America sales of...